Published in Postgrad Med J on September 01, 2002
Management of anastrozole-induced bone loss in breast cancer patients with oral risedronate: results from the ARBI prospective clinical trial. Breast Cancer Res (2010) 1.30
The clinical utility of bone marker measurements in osteoporosis. J Transl Med (2013) 1.21
Poor histological healing of a femoral fracture following 12 months of oestrogen deficiency in rats. Osteoporos Int (2013) 0.79
Bisphosphonate treatment in ochronotic osteoporotic patients. Clin Rheumatol (2006) 0.79
Expressions and clinical significance of serum bone Gla-protein, bone alkaline phosphatase and C-terminal telopeptide of type I collagen in bone metabolism of patients with osteoporosis. Pak J Med Sci (2015) 0.78
Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med (2001) 16.81
Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet (1996) 13.20
Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med (1995) 13.01
Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ (1996) 11.60
A multifactorial intervention to reduce the risk of falling among elderly people living in the community. N Engl J Med (1994) 11.54
Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA (1999) 11.23
Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl J Med (1995) 10.99
Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med (1992) 9.86
Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med (2001) 9.57
Hip fractures in the elderly: a world-wide projection. Osteoporos Int (1992) 9.08
Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med (1997) 6.88
Prevention of falls in the elderly trial (PROFET): a randomised controlled trial. Lancet (1999) 5.37
Hormone replacement therapy and prevention of nonvertebral fractures: a meta-analysis of randomized trials. JAMA (2001) 5.09
A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med (1999) 4.91
Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. Osteoporos Int (2000) 4.85
A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res (1998) 4.24
Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med (1992) 4.19
Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. N Engl J Med (1990) 4.10
Effect of external hip protectors on hip fractures. Lancet (1993) 4.06
The effect of postmenopausal estrogen therapy on bone density in elderly women. N Engl J Med (1993) 4.04
Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. N Engl J Med (1990) 3.76
Risk factors for falls as a cause of hip fracture in women. The Northeast Hip Fracture Study Group. N Engl J Med (1991) 3.39
Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy. Am J Med (1993) 3.23
Fall-related factors and risk of hip fracture: the EPIDOS prospective study. Lancet (1996) 3.18
Alendronate for the treatment of osteoporosis in men. N Engl J Med (2000) 3.11
An update on the diagnosis and assessment of osteoporosis with densitometry. Committee of Scientific Advisors, International Osteoporosis Foundation. Osteoporos Int (2000) 2.99
Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest (2000) 2.94
Prediction of osteoporotic fractures by postural instability and bone density. BMJ (1993) 2.93
Vitamin D supplementation and fracture incidence in elderly persons. A randomized, placebo-controlled clinical trial. Ann Intern Med (1996) 2.66
Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women. BMJ (1994) 2.61
Annual injection of vitamin D and fractures of aged bones. Calcif Tissue Int (1992) 2.23
Parathyroid hormone as a therapy for idiopathic osteoporosis in men: effects on bone mineral density and bone markers. J Clin Endocrinol Metab (2000) 2.14
Rheumatoid arthritis, corticosteroid therapy and hip fracture. Ann Rheum Dis (1995) 2.10
Effect of calcium or 25OH vitamin D3 dietary supplementation on bone loss at the hip in men and women over the age of 60. J Clin Endocrinol Metab (2000) 2.09
Association of hypogonadism and estradiol levels with bone mineral density in elderly men from the Framingham study. Ann Intern Med (2000) 2.02
Will elderly rest home residents wear hip protectors? Age Ageing (1998) 1.95
Maternal height, childhood growth and risk of hip fracture in later life: a longitudinal study. Osteoporos Int (2001) 1.91
Testosterone therapy in glucocorticoid-treated men. Arch Intern Med (1996) 1.82
Monitoring osteoporosis therapy with bone densitometry: misleading changes and regression to the mean. Fracture Intervention Trial Research Group. JAMA (2000) 1.79
Anabolic effect of low doses of a fragment of human parathyroid hormone on the skeleton in postmenopausal osteoporosis. Lancet (1976) 1.73
Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormone. J Bone Miner Res (1992) 1.67
Progressive loss of bone in the femoral neck in elderly people: longitudinal findings from the Dubbo osteoporosis epidemiology study. BMJ (1994) 1.51
Forearm fractures as predictors of subsequent osteoporotic fractures. Osteoporos Int (1999) 1.50
Castrated men exhibit bone loss: effect of calcitonin treatment on biochemical indices of bone remodeling. J Clin Endocrinol Metab (1989) 1.31
Osteoporosis in men. J Clin Endocrinol Metab (1999) 1.29
Effect of salcatonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study. BMJ (1992) 1.27
Low levels of estradiol are associated with vertebral fractures in older men, but not women: the Rancho Bernardo Study. J Clin Endocrinol Metab (2000) 1.23
Maternal weight gain in women with good pregnancy outcome. Obstet Gynecol (1990) 1.12
Management of male osteoporosis: report of the UK Consensus Group. QJM (1998) 1.10
Pathogenesis of vertebral crush fractures in men. Age Ageing (1992) 1.05
Risk factors for osteoporosis. Clin Endocrinol (Oxf) (1992) 1.03
Long-term substitution therapy of hypogonadal men with transscrotal testosterone over 7-10 years. Clin Endocrinol (Oxf) (1999) 1.03
Salmon calcitonin reduces vertebral fracture rate in postmenopausal crush fracture syndrome. Bone Miner (1992) 1.02
Indicators of lifetime estrogen exposure: effect on breast cancer incidence and interaction with raloxifene therapy in the multiple outcomes of raloxifene evaluation study participants. J Clin Oncol (2001) 1.01
Predictors of hip fractures in elderly men. J Bone Miner Res (1995) 1.01
Androgen supplementation in eugonadal men with osteoporosis: effects of six months' treatment on markers of bone formation and resorption. J Bone Miner Res (1997) 1.00
Alendronate treatment of established primary osteoporosis in men: results of a 2-year prospective study. J Clin Endocrinol Metab (2001) 0.96
Novel insights into the pathogenesis of osteoporosis: the role of intrauterine programming. Rheumatology (Oxford) (2000) 0.94
HRT and Vit D in prevention of non-vertebral fractures in postmenopausal women; a 5 year randomized trial. Maturitas (1998) 0.93
Is distal forearm fracture in men due to osteoporosis? Osteoporos Int (2002) 0.93
Hormone replacement therapy and prevention of vertebral fractures: a meta-analysis of randomised trials. BMC Musculoskelet Disord (2001) 0.93
Pain relief from nasal salmon calcitonin in osteoporotic vertebral crush fractures. A double blind, placebo-controlled clinical study. Acta Orthop Scand Suppl (1997) 0.90
Hyperthyroidism and calcium metabolism. Clin Endocrinol Metab (1973) 0.85
Effect of calcitonin on vertebral and other fractures. QJM (1999) 0.81
Effects of calcitriol or calcium on bone mineral density, bone turnover, and fractures in men with primary osteoporosis: a two-year randomized, double blind, double placebo study. J Clin Endocrinol Metab (2001) 0.81
Sex hormones and osteoporosis in men. Calcif Tissue Int (1998) 0.80
Pathogenesis of vertebral crush fractures in women. J R Soc Med (1994) 0.78
Risk factors for osteoporosis in men. Clin Endocrinol (Oxf) (1993) 0.78
Management of established osteoporosis. Br J Clin Pharmacol (1998) 0.76
Patients with learning disability in the community. BMJ (1999) 4.19
A UK Consensus Group on management of glucocorticoid-induced osteoporosis: an update. J Intern Med (1998) 2.42
Comparison of ultrasound measurements at the heel between adults with mental retardation and control subjects. Bone (1998) 1.97
Efficacy and safety of strontium ranelate in the treatment of osteoporosis in men. J Clin Endocrinol Metab (2013) 1.77
Steroid hormones, ageing and bone. Clin Endocrinol Metab (1981) 1.56
The reliability of diagnosing osteoporosis from spinal radiographs. Age Ageing (1994) 1.45
Consequences of withholding testosterone treatment. Lancet (1996) 1.14
Low bone mineral content is common but osteoporotic fractures are rare in elderly rural Gambian women. J Bone Miner Res (1996) 1.14
The effects of sex steroid and corticosteroid hormones on bone. J Steroid Biochem (1981) 1.12
Androgen supplementation in eugonadal men with osteoporosis-effects of 6 months of treatment on bone mineral density and cardiovascular risk factors. Bone (1996) 1.12
Staining of the calcification front in human bone using contrasting fluorochromes in vitro. J Histochem Cytochem (1984) 1.10
Management of male osteoporosis: report of the UK Consensus Group. QJM (1998) 1.10
The increasing use of peripheral bone densitometry. BMJ (2000) 1.08
Pathogenesis of vertebral crush fractures in men. Age Ageing (1992) 1.05
Proceedings of the Rank Forum on Vitamin D. Br J Nutr (2010) 1.05
Case-control study of the pathogenesis and sequelae of symptomatic vertebral fractures in men. Osteoporos Int (1999) 1.01
Androgen supplementation in eugonadal men with osteoporosis: effects of six months' treatment on markers of bone formation and resorption. J Bone Miner Res (1997) 1.00
Osteoporosis in hypogonadal men: role of decreased plasma 1,25-dihydroxyvitamin D, calcium malabsorption, and low bone formation. Bone (1986) 0.99
Renal impairment and its effects on calcium metabolism in elderly women. Age Ageing (1984) 0.96
Urogenital ageing and its effect on sexual health in older British women. Br J Obstet Gynaecol (1997) 0.94
Mitochondrial DNA deletion associated oxidative stress and severe male osteoporosis. Osteoporos Int (1999) 0.92
Contrasting microanatomy of idiopathic and corticosteroid-induced osteoporosis. Clin Orthop Relat Res (1989) 0.91
The sequelae of vertebral crush fractures in men. Osteoporos Int (1994) 0.90
National Osteoporosis Society's Position statement on hormone replacement therapy in the prevention and treatment of osteoporosis. Menopause Int (2011) 0.89
Calcium malabsorption in the elderly: the effect of treatment with oral 25-hydroxyvitamin D3. Eur J Clin Invest (1983) 0.88
Sex steroids and bone turnover markers in men with symptomatic vertebral fractures. Bone (2008) 0.88
Osteoporosis in men. Best Pract Res Clin Rheumatol (2001) 0.87
A randomized controlled trial of calcium with vitamin D, alone or in combination with intravenous pamidronate, for the treatment of low bone mineral density associated with Crohn's disease. Aliment Pharmacol Ther (2003) 0.87
Vitamin D binding protein gene in male osteoporosis: association of plasma DBP and bone mineral density with (TAAA)(n)-Alu polymorphism in DBP. Calcif Tissue Int (1999) 0.87
Endocrinology and osteoporosis. J Endocrinol (1988) 0.86
Calcaneal bone mineral density in older patients who have fallen. QJM (2006) 0.86
Suppression of bone turnover by B-cell depletion in patients with rheumatoid arthritis. Osteoporos Int (2011) 0.86
Calcium malabsorption in elderly women with vertebral fractures: evidence for resistance to the action of vitamin D metabolites on the bowel. Clin Sci (Lond) (1984) 0.85
Plasma vitamin D and cytokines in periodontal disease and postmenopausal osteoporosis. J Periodontal Res (2010) 0.84
Plasma total and ionised calcium, albumin and globulin concentrations in pre- and post-menopausal women and the effects of oestrogen administration. Clin Chim Acta (1982) 0.84
Differences in bone mineral density and geometry in men and women: the Newcastle Thousand Families Study at 50 years old. Br J Radiol (2005) 0.83
Vitamin D-binding protein gene microsatellite polymorphism influences BMD and risk of fractures in men. Osteoporos Int (2007) 0.83
Secondary prevention of osteoporosis: when should a non-vertebral fracture be a trigger for action? QJM (2001) 0.83
FRAX-based assessment and intervention thresholds--an exploration of thresholds in women aged 50 years and older in the UK. Osteoporos Int (2015) 0.82
Influence of IL-6, COL1A1, and VDR gene polymorphisms on bone mineral density in Crohn's disease. Gut (2005) 0.81
Femoral neck shaft angle in men with fragility fractures. J Osteoporos (2011) 0.81
Intravenous bisphosphonate prevents symptomatic osteoporotic vertebral collapse in patients after liver transplantation. Liver Transpl Surg (1998) 0.80
Effect of intermittent cyclical disodium etidronate therapy on bone mineral density in men with vertebral fractures. Age Ageing (1997) 0.80
Sex hormones and osteoporosis in men. Calcif Tissue Int (1998) 0.80
Vitamin D receptor gene start codon polymorphism (FokI) and bone mineral density in healthy male subjects. Clin Endocrinol (Oxf) (2000) 0.80
Local action of oral 1,25-dihydroxycholecalciferol on calcium absorption in osteoporosis. Am J Clin Nutr (1987) 0.79
Hormone replacement therapy (HRT) or etidronate for osteoporosis in postmenopausal asthmatics on glucocorticoids: a randomised factorial trial. Scott Med J (2009) 0.79
Reduced gastrointestinal absorption of calcium in dementia. Age Ageing (1990) 0.79
Osteoporosis in men. Baillieres Clin Rheumatol (1993) 0.79
Risk factors for osteoporosis in men. Clin Endocrinol (Oxf) (1993) 0.78
Is synovial fluid analysis of diagnostic value? Br J Clin Pract (1982) 0.78
Five-year follow-up of oestrogen therapy in 94 women. Maturitas (1982) 0.78
Pathogenesis of vertebral crush fractures in women. J R Soc Med (1994) 0.78
Mutational and polymorphic analysis of the estradiol receptor-alpha gene in men with symptomatic vertebral fractures. Calcif Tissue Int (2002) 0.78
What can we learn about vitamin D requirements from post-mortem data? Osteoporos Int (2013) 0.77
Age and Ageing. Editor's view. Age Ageing (2009) 0.77
A comparison of the effect of sorbitol and glucose on calcium absorption in postmenopausal women. Am J Clin Nutr (1986) 0.77
Distal forearm fracture--time for action? Age Ageing (2001) 0.77
The vitamin D paradox. Rheumatology (Oxford) (2007) 0.76
Hypercalcaemia due to the coexistence of parathyroid adenoma and myelomatosis. J Clin Pathol (1982) 0.76
Calcium and vitamin D supplementation and cardiovascular disease: quo vadis? Maturitas (2011) 0.76
A lifecourse study of bone resorption in men ages 49-51years: the Newcastle Thousand Families cohort study. Bone (2010) 0.76
Vitamin D deficiency--can old age learn from childhood? Age Ageing (2008) 0.75
Age and ageing. Editor's view. Age Ageing (2008) 0.75
Acute effects of saline, calcitonin, and hydrocortisone on plasma calcium in vitamin D intoxication. Br Med J (1979) 0.75
Thyrotoxicosis presenting as fracture of femoral neck. Br Med J (Clin Res Ed) (1982) 0.75
Editor's note. Error in Table 3 in the paper by Saka and colleagues. Age Ageing (2009) 0.75
Here comes the sun: good news for bone health! Age Ageing (2010) 0.75
Milk intake and bone mineral acquisition in adolescent girls. Results in two groups are not so different. BMJ (1998) 0.75
Evolution of osteoporosis. Ann Rheum Dis (1997) 0.75
Senile and postmenopausal osteoporosis. Horm Res (1984) 0.75
If my wife had osteoporosis. Br J Clin Pract (1989) 0.75
Treating osteoporosis: boning up. Geriatr Nurs Home Care (1988) 0.75
Editor's view. Age Ageing (2008) 0.75
Editor's view. Age Ageing (2008) 0.75
Are scintigrams of the spine useful in vertebral osteoporosis? Clin Radiol (1986) 0.75
Confusion over a missing social security cheque. Lancet (1996) 0.75
Editor's view. Age Ageing (2011) 0.75
Editor's view. Age Ageing (2008) 0.75
Chronic active hepatitis presenting with Mirizzi syndrome. Br J Clin Pract (1988) 0.75
Bone formation and resorption as the determinants of trabecular bone volume in normal and osteoporotic men. Scott Med J (1984) 0.75
Vitamin D and fractures: where are we now? Maturitas (2010) 0.75
Editor's view. Age Ageing (2008) 0.75
Norethisterone in postmenopausal osteoporosis. Br J Hosp Med (1987) 0.75
Age and Ageing. Editor's view. Age Ageing (2009) 0.75
Fracture prevention in care home residents: is vitamin D supplementation enough? Age Ageing (2006) 0.75
Editor's view. Age Ageing (2009) 0.75
Urinary free deoxypyridinoline by chemiluminescence immunoassay: analytical and clinical evaluation. Clin Chem (1998) 0.75
Male osteoporosis. Rheumatology (Oxford) (2000) 0.75
Magnitude of fragility fracture risk in the very old--are we meeting their needs? The Newcastle 85+ Study. Osteoporos Int (2014) 0.75
Steroid-induced bone disease. Conflicting views of respiratory and bone physicians. J R Coll Physicians Lond (1992) 0.75